Related article: Resources for patients
- For Patients
- Introduction to the Marshall Protocol
- Length of the MP
- Immunopathology
- Managing immunopathology
- Food and drink
- Light restriction
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Starting the Marshall Protocol
- Resources for patients
- Marshall Protocol summary
- Palliative vs. curative treatments
- Patient interviews on Bacteriality
- Non-MP treatments
- Glossary
- The Protocol
- Marshall Protocol summary
- Publications and presentations
- Science behind immunopathology
- Science behind olmesartan (Benicar)
- Safety of olmesartan
- Resources for physicians
- Vitamin D metabolite calculator - get feedback on vitamin D results
- Therapeutic probe - best method for determining MP suitability
- Physicians' concerns about the MP
- Notice for emergency medical personnel
- The Pathogenesis
- Publications and presentations
- Science behind Marshall Pathogenesis
- Microbes in the human body
- Successive infection and variability in disease
- Autoimmune theory of disease
- Science behind vitamin D
- Metabolism of vitamin D and the VDR
- Th1 Spectrum Disorder - how chronic inflammatory diseases are related
- Transmission of bacteria and onset of chronic disease
- Evolutionary perspective on disease
- Incidence and prevalence of disease
- Evidence that chronic disease is caused by pathogens
- Diseases
- Foundation
- Related Sites
Table of Contents
<html> <style type=“text/css”> div.dokuwiki table.inline .row0 {background-color: rgb(105,100,100); color: #eee !important; font-weight: bold;} div.dokuwiki table.inline .row0 a {color: #fff !important;} div.dokuwiki table.inline .row0 a:hover {color: #000 !important;} .col0 {font-weight: bold;} </style> </html>
Starting the Marshall Protocol
Patients intent upon beginning the Marshall Protocol should familiarize themselves with the various resources and Knowledge Base articles available to the them including:
- One-article summary of the Marshall Protocol – links to a lot of helpful content in the Knowledge Base
Important:
The Autoimmunity Research FoundationNon-profit foundation dedicated to exploring a pathogenesis and therapy for chronic disease. does not support or license the public use of this therapy for patients not actively participating on the Marshall Protocol study site at MarshallProtocol.com.
The MP Knowledge Base is partly based on that ongoing longitudinal study supported by the ARF and described below.
Anyone with one or more Auto-immune diagnoses, also anyone with long term medical problems which resist diagnosis, is invited to register.
It is most helpful to the progress of the research, for you then to post if applicable, your decision to postpone, suspend or discontinue use of Olmesartan medoxomil with your reason(s) for this decision.
where this applies, we also would appreciate a brief summary annually or less frequently, to follow up your welfare, in order to make it possible for the research team to analyze outcomes over a ten year period or longer when possible.
If you rarely post progress or take part in other discussion, you may find it necessary to ask for your personal topic to be reactivated. You may send an email to our Admin Staff with a request Thank you
Support Team members.
Online research and support community
The Autoimmunity Research Foundation provides access to a lively online research and support community where the posted experiences of our members have been used to inform directions for new paradigms for recovery from Th1 illness. Member reports of response to various environmental, pharmaceutical and dietary events has also allowed for a more dynamic level of feedback for ongoing research.
In order to join in the conversation, please follow these instructions for How to Register.
Checklist for starting the MP
Before beginning the Marshall Protocol, patients are required to review the Checklist for starting the Marshall Protocol.
Safety warnings
Main article: Safety warnings for the Marshall Protocol
The Marshall Protocol (MP) is a powerful therapy for immune function recovery and must be followed exactly. Every aspect of the MP is designed with a patient's safety in mind. Patients intent on beginning the MP should first ensure that they have completed all the items on the checklist before they begin.
Working with a physician
Main article: Working with a physician
Related articles: 5 key elements of MP
Patients on the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP) must work with a licensed physician or other healthcare practitioner, such as a nurse practitioner or physician's assistant. Patients who have the most successful outcomes are proactive and prepared. They internalize the requirements for the MP and, when necessary, work to address any of their physicians' concerns about the treatment. At this point, no doctors are certified in the use of the MP.
Finding a physician
Main article: Finding a physician
Related article: Convincing a reluctant physician to prescribe the Marshall Protocol
Generally speaking, it often makes the most sense to work with one's existing doctor when getting on the Marshall Protocol.
Patients who educate themselves, before approaching their doctor, have the most success in getting their doctor to partner with them in their recovery. Especially when they show the initiative to print out the published research and can explain their plan with confidence.
Any doctor's knowledge about the MP is likely very limited. Even those doctors who are the most familiar with the protocol will not always have the time to stay current with the latest sources of information such as conferences and publications.
Many patients find that their doctors appreciate when they take the time to provide copies of newly published papers about the protocol. Some patients forward electronic copies (PDFs) to their doctor's email. Some doctors appreciate when their patients provide paper copies with key points highlighted. We recommend you discuss with your doctor how they would prefer to be kept up to date.
Medical practice is oriented towards “intervention-as-first-response” for nearly everything.
The idea that a human body could recover by removing the burdens being put on it has not quite taken off yet.
Joyful March 2017
Therapeutic probe
Main article: Therapeutic probe
<html></p><div class=“mainarticle”>Related article:</html> Vitamin D metabolite calculator
Used in the context of the Marshall ProtocolA curative medical treatment for chronic inflammatory disease. Based on the Marshall Pathogenesis. (MP), a therapeutic probeA brief trial of the Marshall Protocol to see if it will generate an immunopathological response. The "gold standard" for testing whether a patient is a good candidate for the MP. refers to a brief trial of the MP, in which patients take regular doses of olmesartan (Benicar)Medication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. and restrict consumption of vitamin D. The presence of a positive treatment response is taken as an indication that a patient is sick with Th1 diseaseAny of the chronic inflammatory diseases caused by bacterial pathogens. and that the MP is a treatment option for that disease. Although there are other factors and variables, which can strongly suggest the presence of Th1 disease, the therapeutic probe is currently the best method for determining if the MP may be suitable for a patient.
In the context of the therapeutic probe, there are at least three responses or types of responses which indicate that continued treatment with the MP is warranted:
- photosensitivityAbnormal sensitivity to sunlight and bright lights. Also referred to as "sun flare" or "light flare." – Even if patients have never been light sensitive before, they may find lights to be too bright for comfort. Patients are cautioned that photosensitivity (and other symptoms) can occur in response to a withdrawal of typical levels of light exposure, even before the use of olmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. is commenced.
- noticeable spike in symptoms – Replacing 'vitamin' D in the VDRThe Vitamin D Receptor. A nuclear receptor located throughout the body that plays a key role in the innate immune response., Benicar ensures reactivation of the innate immune responseThe body's first line of defense against intracellular and other pathogens. According to the Marshall Pathogenesis the innate immune system becomes disabled as patients develop chronic disease., allowing destruction of pathogenic bacteria and viruses. The effect of a strengthened immune system response is called immunopathologyA temporary increase in disease symptoms experienced by Marshall Protocol patients that results from the release of cytokines and endotoxins as disease-causing bacteria are killed.. Immunopathology feels bad because the killing of bacteria generates cytokinesAny of various protein molecules secreted by cells of the immune system that serve to regulate the immune system., endotoxins, and nitric oxide.
- noticeable relief in symptoms – As an ARBA drug which is an angiotensin receptor blocker. One of the ARBs is olmesartan (Benicar). Not all ARBs activate the Vitamin D Receptor., Benicar has profound anti-inflammatory effects, which manifest in a reduction in pain, fatigue, and other symptoms of Th1 disease.
Symptoms which wax and wane in tandem with an every-other-day administration of antibiotics are an especially strong indication of Th1 disease.
It is expected that the way a patient responds to the MP will change over time.
Special circumstance – withdrawing vitamin D before starting olmesartan
Some patients who have difficulty finding a supportive doctor or have practical reasons to delay taking the MP medications want to do what they can immediately to start the healing process. Eliminating vitamin D (food and supplements) and avoiding natural or bright light exposure are measures that can be followed prior to a doctor's prescription and may make a patient feel better. It may also allow the immune system to begin functioning and killing bacteria, thus provoking an immune system reaction. This will cause an increase in symptoms (perhaps intolerable) and possibly an increase in inflammation to joints and organs not yet protected by olmesartanMedication taken regularly by patients on the Marshall Protocol for its ability to activate the Vitamin D Receptor. Also known by the trade name Benicar. .
Withdrawing vitamin D is encouraged but patients who are not starting olmesartan yet should proceed with caution. All prospective patients, but particularly those who have not yet started olmesartan, should read about a potential withdrawal reaction from light restriction.
Notes and comments
— Sallie Q 03.04.2016 adding three sentences before second par on Online research community and modifying what appears to be an error by creating a 'note important' box around the statement commenced with “Important” twice
added to link list *Tools for doing the Marshall Protocol — Sallie Q 24 Jly '15
CureMyTh1.org references removed during transition to closing that site. — Joyful 01.04.2014
home/starting.txt · Last modified: 07.04.2022 by 127.0.0.1
© 2015, Autoimmunity Research Foundation. All Rights Reserved.